CTLA4 and neoplasm: It is well known that cytotoxic T-lymphocyte-associated protein 4(CTLA-4) and programmed death 1 (PD1)/programmed cell death-Ligand 1(PD-L1) have been demonstrated to be important checkpoints that block anti-tumor immune responses.